Paul Gama

Paul Gama is the leader of P&G’s Personal Healthcare group in
North America. In this role, he manages and delivers the overall
P&L for a portfolio that includes Vick’s (Dayquil, Nyquil, Sinex and
Zzzquil), Prilosec, Pepto Bismol, Align, Metamucil and New
Chapter. His responsibilities include leading the development and
execution of the short and long term brand marketing strategy,
advertising, selling and product innovation plans for the business.